Jamal Rushdy

Jamal Rushdy

Director Ejecutivo en
MIACH Orthopaedics, Inc.
.
55 años
Health Technology
Consumer Services
Health Services

Perfil

Jamal David Rushdy is currently President & Chief Executive Officer at MIACH Orthopaedics, Inc. since 2026.
Mr. Rushdy is Chairman at SetBone Medical Ltd. Mr. Rushdy is Director at Collagen Solutions (UK) Ltd. since 2016.
Mr. Rushdy is Director at Collagen Solutions NZ Ltd. since 2016.
Mr. Rushdy is Director at FocusStart LLC.
Formerly, Mr. Rushdy was Chief Executive Officer & Director at Collagen Solutions (US) LLC from 2016 to 2020.
Mr. Rushdy was Director-Marketing & Business Development at DJO LLC in 2006.
Mr. Rushdy was Vice President-Operations & Business Development at Nexa Orthopedics, Inc. from 2006 to 2007.
Mr. Rushdy was General Manager at Futura Biomedical LLC.
Mr. Rushdy was VP-Global Sports Medicine, Biologics & Business Development at Tornier NV in 2011.
Mr. Rushdy was Vice President at Tornier, Inc. Education includes an MBA from Paul Merage School of Business.

Cargos activos de Jamal Rushdy

EmpresasCargoInicio
Director/Miembro de la Junta 01/10/2016
Director/Miembro de la Junta 11/10/2016
Director/Miembro de la Junta -
Presidente -
Director Ejecutivo 18/05/2026

Antiguos cargos conocidos de Jamal Rushdy.

EmpresasCargoFin
COLLAGEN SOLUTIONS PLC Director Ejecutivo 02/04/2024
Director de Operaciones 01/05/2007
Ventas & Marketing 01/01/2006
Director Ejecutivo -
░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Ver el detalle de la experiencia de Jamal Rushdy.

Formación de Jamal Rushdy.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

5

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas14

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN